A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing

被引:496
作者
Pierce, Christopher G. [1 ,2 ]
Uppuluri, Priya [1 ,2 ]
Tristan, Amanda R. [1 ,2 ]
Wormley, Floyd L., Jr. [1 ,2 ]
Mowat, Eilidh [3 ]
Ramage, Gordon [3 ]
Lopez-Ribot, Jose L. [1 ,2 ]
机构
[1] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA
[2] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA
[3] Glasgow Dent Hosp & Sch, Sect Infect & Immun, Glasgow G2 3JZ, Lanark, Scotland
关键词
D O I
10.1038/nprot.2008.141
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The incidence of fungal infections has increased significantly over the past decades. Very often these infections are associated with biofilm formation on implanted biomaterials and/or host surfaces. This has important clinical implications, as fungal biofilms display properties that are dramatically different from planktonic (free-living) populations, including increased resistance to antifungal agents. Here we describe a rapid and highly reproducible 96-well microtiter-based method for the formation of fungal biofilms, which is easily adaptable for antifungal susceptibility testing. This model is based on the ability of metabolically active sessile cells to reduce a tetrazolium salt (2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide) to water-soluble orange formazan compounds, the intensity of which can then be determined using a microtiter-plate reader. The entire procedure takes approximately 2 d to complete. This technique simplifies biofilm formation and quantification, making it more reliable and comparable among different laboratories, a necessary step toward the standardization of antifungal susceptibility testing of biofilms.
引用
收藏
页码:1494 / 1500
页数:7
相关论文
共 32 条
[1]   Biofilm matrix of Candida albicans and Candida tropicalis:: chemical composition and role in drug resistance [J].
Al-Fattani, Mohammed A. ;
Douglas, L. Julia .
JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (08) :999-1008
[2]   In vitro activity of caspofungin against Candida albicans biofilms [J].
Bachmann, SP ;
VandeWalle, K ;
Ramage, G ;
Patterson, TF ;
Wickes, BL ;
Graybill, JR ;
López-Ribot, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3591-3596
[3]   Antifungal combinations against Candida albicans biofilms in vitro [J].
Bachmann, SP ;
Ramage, G ;
VandeWalle, K ;
Patterson, TF ;
Wickes, BL ;
López-Ribot, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3657-3659
[4]   Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents [J].
Baillie, GS ;
Douglas, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1900-1905
[5]   Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B [J].
Baillie, GS ;
Douglas, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2146-2149
[6]   Recent trends in the epidemiology of invasive mycoses [J].
Clark, TA ;
Hajjeh, RA .
CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (06) :569-574
[7]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[8]  
Dixon DM, 1996, PUBLIC HEALTH REP, V111, P226
[9]   Biofilms: Microbial life on surfaces [J].
Donlan, RM .
EMERGING INFECTIOUS DISEASES, 2002, 8 (09) :881-890
[10]   Candida albicans biofilms:: a developmental state associated with specific and stable gene expression patterns [J].
García-Sánchez, S ;
Aubert, S ;
Iraqui, I ;
Janbon, G ;
Ghigo, JM ;
d'Enfert, C .
EUKARYOTIC CELL, 2004, 3 (02) :536-545